Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
May 3 NVO This Is a Huge Sigh of Relief for Novo Nordisk Investors
May 3 NVO Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
May 3 NVO Novo slides as Amgen fuels obesity drug competition fears
May 3 NVO Here’s How Novo Holdings’ Catalent (CTLT) Acquisition Affects Laughing Water Capital
May 2 NVO Weight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
May 2 NVO Novo Nordisk slides while Moderna pops: Tale of two pharma stocks
May 2 NVO Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK
May 2 NVO Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
May 2 NVO Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript
May 2 NVO Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
May 2 NVO Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation
May 2 NVO Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript
May 2 NVO Top Midday Stories: Novo Nordisk, Linde Shares Fall Post-Earnings; Peloton Shares Plummet After Announcing Job Cuts, CEO Change; Exxon-Pioneer Deal Gets FTC Approval With One Caveat
May 2 NVO Novo Nordisk Stock Falls After Pricing Pressure Mounts for Wegovy
May 2 NVO Novo Nordisk Dips After Wegovy Sales Double, But Miss Analysts' Forecast
May 2 NVO GLP-1 drug prices falling at UK pharmacies, clinics: report
May 2 NVO Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
May 2 NVO Novo Nordisk says prices dropping for Wegovy, Ozempic: report
May 2 NVO Novo Nordisk Lifts Full-Year Sales Outlook as Obesity, Diabetes Drugs Drive First-Quarter Topline Beat
May 2 NVO UPDATE 1-Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags